Metabolic control of sodium transport in streptozotocin-induced diabetic rat hearts

Biochemistry (Mosc). 2000 Apr;65(4):502-8.

Abstract

Diabetic and control cardiomyocytes encapsulated in agarose beads and superfused with modified medium 199 were studied with 23Na- and 31P-NMR. Baseline intracellular Na+ was higher in diabetic (0.076 +/- 0.01 micromoles/mg protein) than in control (0.04 +/- 0.01 micromoles/mg protein) (p < 0.05). Baseline betaATP and phosphocreatine (PCr) (peak area divided by the peak area of the standard, methylene diphosphonate) were lower in diabetic than in control, e.g., betaATP control, 0.70 +/- 0.07; betaATP diabetic, 0. 49 +/- 0.04 (p < 0.027); PCr control, 1.20 +/- 0.13; PCr diabetic, 0. 83 +/- 0.11 (p < 0.03). This suggests that diabetic cardiomyocytes have depressed bioenergetic function, which may contribute to abnormal Na,K-ATPase function, and thus, an increase in intracellular Na+. In the experiments presented herein, three interventions (2-deoxyglucose, dinitrophenol, or ouabain infusions) were used to determine whether, and the extent to which, energy deficits or abnormalities in Na,K-ATPase function contribute to the increase in intracellular Na+. In diabetic cardiomyocytes, 2-deoxyglucose and ouabain had minimal effect on intracellular Na+, suggesting baseline depression of, or resetting of both glycolytic and Na,K-ATPase function, whereas in control both agents caused significant increases in intracellular Na+after 63 min exposure: 2-deoxyglucose control, 32.9 +/- 8.1%; 2-deoxyglucose diabetic, -4.6 +/- 6% (p < 0.05); ouabain control, 50.5 +/- 8.8%; ouabain diabetic, 21.2 +/- 9.2% (p < 0.05). In both animal models, dinitrophenol was associated with large increases in intracellular Na+: control, 119.0 +/- 26.9%; diabetic, 138.2 +/- 12.6%. Except for the dinitrophenol intervention, where betaATP and PCr decreased to levels below 31P-NMR detection, the energetic metabolites were not lowered to levels that would compromise sarcolemmal function (Na,K-ATPase) in either control or diabetic cardiomyocytes. In conclusion, in diabetic cardiomyocytes, even though abnormal glycolytic and Na, K-ATPase function was associated with increases in intracellular Na+, these increases were not directly related to global energy deficit.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2,4-Dinitrophenol / pharmacology
  • Animals
  • Antimetabolites / pharmacology
  • Biological Transport
  • Case-Control Studies
  • Cells, Cultured
  • Deoxyglucose / pharmacology
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Magnetic Resonance Spectroscopy
  • Male
  • Myocardium / metabolism*
  • Ouabain / pharmacology
  • Perfusion
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Sodium / metabolism*
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Streptozocin
  • Time Factors
  • Uncoupling Agents / pharmacology

Substances

  • Antimetabolites
  • Enzyme Inhibitors
  • Uncoupling Agents
  • Ouabain
  • Streptozocin
  • Deoxyglucose
  • Sodium
  • Sodium-Potassium-Exchanging ATPase
  • 2,4-Dinitrophenol